Disposable Bioreactors Based on Wave Agitation Technology - Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes. - BioPharm

ADVERTISEMENT

Disposable Bioreactors Based on Wave Agitation Technology
Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes.


BioPharm International


DIANA MARJANOVIC is a product manager of disposable bioreactors at Sartorius AG, Switzerland. Gerhard Greller is a scientist in process development, biotechnology, at Sartorius AG, Germany.

References

1. L. Stryer L. Biochemistry, 4th ed. New York (NY): W.H. Freeman and Company; 1995.

2. Wurm F. Nature Biotech 2004;22: 13–98.

3. Sandig V. et al. Mammalian cells. In: Gelissen G., editor. Production of recombinant proteins. (Wiley-VCH; 2005)

4. Weber W. et al. Catching the Wave: The BEVS and the Biowave. Novartis Pharma Research, Switzerland.

5. Eibl D. and Eibl R. BioWorld 2005; 3:1–2 (Supplement BioteCHnet)

6. Pierce, Bioprocessing J 2004; 3: 51–56.

7. Ling et al., Biotechnol Prog 2003; 19(1), 158–62

8. Weber W. et al. Cytotechn 2002; 38: 77–85.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here